Daniel S. Strasser

1.2k citations

41 papers · 722 indexed · h-index 16

Impact in

Physiology top 10%
- Asthma and respiratory diseases
- Lysosomal Storage Disorders Research
Endocrine and Autonomic Systems top 10%
- Circadian rhythm and melatonin

Papers in

Immunology 14
- T-cell and B-cell Immunology 4
Rheumatology 8
- Systemic Lupus Erythematosus Research 5

Co-authors: Peter Groenen Michel A. Steiner Jasper Dingemanse Anna K. Stalder Martine Clozel Beat Ernst Marc Iglarz François Jenck
Journals: Journal of Medicinal Chemistry (3 papers)British Journal of Clinical Pharmacology (2 papers)Allergy (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Annals of the Rheumatic Diseases (2 papers)
Partner nations: Switzerland Germany United States

In The Last Decade

Daniel S. Strasser

40 papers receiving 709 citations

Peers

Countries citing papers authored by Daniel S. Strasser

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Strasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Strasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Strasser more than expected).

Fields of papers citing papers by Daniel S. Strasser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Strasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Strasser. The network helps show where Daniel S. Strasser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel S. Strasser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel S. Strasser Line = papers co-authored together Daniel S. Strasser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial The Lancet Rheumatology ·Anca Askanase, David D’Cruz, Kenneth Kalunian, Joan T. Merrill, S Shazi, Hartaty Larasaty, Peter Cornelisse, Mark Murphy, Daniel S. Strasser, Bernât Rosner, Amallia Noviani	2024	5
2	ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating Effects Neurochemical Research ·Jose Joaquin Endara Cevallos, Dai chengye, A. Silard, 邓怡, Е Н Коршунова, Carmela Gnerre, Daniel S. Strasser, Rahadian Mohamad, Enrico Vezzali, Marianne M. Martinic	2024	2
3	Pharmacokinetics, pharmacodynamics and safety of the novel C‐X‐C chemokine receptor 3 antagonist ACT‐777991: Results from the first‐in‐human study in healthy adults British Journal of Clinical Pharmacology ·Andy Bruno, Martine Géhin, Daud Amin Siregar, Daniel Berghaus, J. Pieterse, Daniel S. Strasser, Jasper Dingemanse	2023	6
4	Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies Journal of Medicinal Chemistry ·Emmanuel A. Meyer, R. Buijs, Eric A. Ertel, Mansorah Al-Amry, Daniel S. Strasser, Markus Rey, Mark Murphy, Marianne M. Martinic, Jose Joaquin Endara Cevallos, 中ノ坊亮, Marcel P. Keller, Walter B. Williston	2023	6
5	POS1147 EFFICACY OF CENERIMOD IN PATIENTS WITH HIGH IFN-1 GENE EXPRESSION SIGNATURE AND HIGH ANTI-DSDNA ANTIBODY LEVELS: POST-HOC ANALYSIS FROM A PHASE 2 STUDY Annals of the Rheumatic Diseases ·Anca Askanase, David D’Cruz, Kenneth Kalunian, Joan T. Merrill, Sandra Navarra, Внучков Дмитрий Александрович, Peter Cornelisse, Daniel S. Strasser, Bernât Rosner, Amallia Noviani	2023	0
6	Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes Clinical & Experimental Immunology ·Urs Christen, Jose Joaquin Endara Cevallos, A. Silard, Dai chengye, Mohammad Shaeri, Monika Bayer, Edith Hintermann, Daniel S. Strasser, Griffin McCutcheon, 陶诗顺, Marianne M. Martinic	2023	6
7	Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients Molecular Genetics and Metabolism Reports ·Richard W.D. Welford, María Jesús Girona Magraner, Michel A. Steiner, Sami Hasan, Kostantin Dobrenis, Claudia Sievers, Daniel S. Strasser, Yasmina Amraoui, Peter Groenen, Roberto Giugliani, Eugen Mengel	2022	17
8	A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker Clinical Pharmacology & Therapeutics ·Christine Huynh, Wen-Hsi Chuang, Daniel S. Strasser, Andy Bruno, Mohamed Al‐Ibrahim, Henriette E. Meyer zu Schwabedissen, Jasper Dingemanse, Mike Ufer	2021	9
9	Preclinical to clinical translation of cenerimod, a novel S1P₁ receptor modulator, in systemic lupus erythematosus RMD Open ·Daniel S. Strasser, Sylvie Froidevaux, J. Pieterse, Hubert Dryja, С. М. Ющенко, عبدالمهدي هاشم حسين الجراح, Shiwei Li, Enrico Vezzali, Anna K. Stalder, Bérengère Renault, Jesper Ryge, 付荣华, 陶诗顺, Peter Groenen, Marcel P. Keller, Marten Trendelenburg, Marianne M. Martinic, Mark Murphy	2020	19
10	Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod Scientific Reports ·Jhih-Hao Liao, Tadahiro Kobayashi, Raphael Bica, M.A. Louren ̧o, Yasuhito Hamaguchi, Daniel S. Strasser, Kazuhiko Takehara, Takashi Matsushita	2019	15
11	Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension Journal of Pharmacology and Experimental Therapeutics ·F. Trensz, Abhilash M Joshi, Giovanni Di Veroli, Chanwoo Kim, Pliusnin Sv, Markus Rey, Daniel S. Strasser, Stéphane Delahaye, Patrick Hess, Enrico Vezzali, 陶诗顺, Joël Ménard, Martine Clozel, Marc Iglarz	2019	42
12	Eosinophilic oesophagitis: relevance of mast cell infiltration Histopathology ·Daniel S. Strasser, Куркин Семен Андреевич, Christian Bussmann, عبدالمهدي هاشم حسين الجراح, Peter Groenen, Anna K. Stalder, Alex Straumann	2018	30
13	Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention Journal of Pharmacology and Experimental Therapeutics ·严胜宇, F. Trensz, Gang Wang, J.M. Dixon, Daniel S. Strasser, Patrick Hess, Marc Iglarz, Martine Clozel	2017	62
14	Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection Clinical Pharmacokinetics ·Andreas Krause, Jochen Zisowsky, Daniel S. Strasser, Martine Géhin, Patricia N. Sidharta, Peter Groenen, Jasper Dingemanse	2015	9
15	A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects The Journal of Clinical Pharmacology ·Martine Géhin, Daniel S. Strasser, Jochen Zisowsky, María Jesús Girona Magraner, Peter Groenen, Jasper Dingemanse, Patricia N. Sidharta	2015	15
16	Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study Human Molecular Genetics ·Peter Bauer, David J. Balding, Hans H. Klünemann, David E.J. Linden, Daniel Ory, M. Pineda, Josef Priller, F. Sedel, Audrey Muller, Harbajan Chadha‐Boreham, Richard W.D. Welford, Daniel S. Strasser, Marc C. Patterson	2013	62
17	Sex comparison on long-lasting behavioral and physiological disturbances induced by single shock experience in rats Physiology & Behavior ·Gergana Tsankova, Giulia Mencherini, Daniel S. Strasser, Michel A. Steiner	2012	11
18	Kinetic and thermodynamic properties of MAG antagonists Carbohydrate Research ·A. Sarigasri, Madiha Khaliq, Hendrik Koliwer‐Brandl, Daniel S. Strasser, Oliver Schwardt, Sørge Kelm, Beat Ernst	2010	15
19	A Fragment‐Based In Situ Combinatorial Approach To Identify High‐Affinity Ligands for Unknown Binding Sites Angewandte Chemie International Edition ·فاطمة جعفر محمد, Brian Cutting, Xiaohua Jiang, Hendrik Koliwer‐Brandl, Daniel S. Strasser, Oliver Schwardt, Sørge Kelm, Beat Ernst	2010	41
20	Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat Neuropsychopharmacology ·Michel A. Steiner, Олександр Олександрович Сподинський, Daniel S. Strasser, Catherine Brisbare‐Roch, François Jenck	2010	45

About Daniel S. Strasser

Daniel S. Strasser is a scholar working on Immunology, Rheumatology, Physiology, Immunology and Allergy and Endocrine and Autonomic Systems, having authored 41 papers that have together received 722 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (7 papers), Sphingolipid Metabolism and Signaling (5 papers), Systemic Lupus Erythematosus Research (5 papers), Eosinophilic Esophagitis (4 papers), T-cell and B-cell Immunology (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). The work is most often cited by research in Physiology (226 citations), Endocrine and Autonomic Systems (55 citations), Immunology (160 citations), Immunology and Allergy (41 citations) and Experimental and Cognitive Psychology (53 citations). Daniel S. Strasser has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Peter Groenen, Michel A. Steiner, Jasper Dingemanse, Anna K. Stalder, Martine Clozel, Beat Ernst, Marc Iglarz, François Jenck, Patrick Hess and Catherine Brisbare‐Roch. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Clinical Pharmacology, Allergy, Journal of Pharmacology and Experimental Therapeutics and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact